Quarterly report pursuant to Section 13 or 15(d)


6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS’ EQUITY

The following table summarizes the Company’s cash dividend activity for the six months ended June 30, 2018 (in thousands, except per share data):
Declaration Date
Per Share
Record Date
Payment Date
April 17, 2018 (special)


May 15, 2018
May 25, 2018
April 17, 2018


May 15, 2018
May 25, 2018
February 6, 2018


February 27, 2018
March 9, 2018



Declaration and payment of any future dividends on shares of common stock will be at the discretion of the Company’s Board of Directors.

Stock Repurchases

On January 12, 2016, the Board of Directors authorized an increase to the Company’s stock repurchase program first approved on July 28, 2015 from $15.0 million to $70.0 million. Repurchases are expected to be executed to the extent that the Company’s earnings and cash-on-hand allow, and will be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. For all or a portion of the authorized repurchase amount, the Company may enter into one or more plans that are compliant with Rule 10b5-1 of the Exchange Act that are designed to facilitate these purchases. The stock repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued. As of June 30, 2018, $32.0 million of the $70.0 million stock repurchase program approved on July 28, 2015 and increased on January 12, 2016 remained available for future purchases, inclusive of related estimated income tax.

Restricted Stock

No stock-based compensation was recognized for the three or six months ended June 30, 2018. Stock-based compensation expense totaled $8,600 and $17,300 for the three and six months ended June 30, 2017, respectively.

At the Company’s annual meeting of stockholders held on April 7, 2016, the Company’s stockholders approved the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “2016 Plan”) to replace its 2007 Equity Incentive Plan. The 2016 Plan allows for the grant of various equity awards including incentive stock options, non-statutory options, stock, stock units, stock appreciation rights and other similar equity-based awards to the Company’s employees, officers, non-employee directors, contractors, consultants and advisors of the Company. Up to 2,500,000 shares of the Company’s common stock (subject to adjustment under certain circumstances) may be issued pursuant to awards granted. At June 30, 2018, 2,359,671 shares remained available for issuance under the 2016 Plan.

On February 1, 2018, the Company granted 34,202 shares of restricted common stock under the 2016 Plan to certain employees for the purpose of further aligning their interest with those of its stockholders and settling fiscal 2017 performance incentives totaling $554,000. The shares vest on a quarterly basis over the next three years and are subject to forfeiture in the event of their termination of service to the Company under specified circumstances.

The following table summarizes the Company’s restricted stock activity under the 2016 Plan:
Wtd. Avg. Price at Date of Issuance
Nonvested at December 31, 2017





Nonvested at June 30, 2018


Accumulated Other Comprehensive Loss
The changes in accumulated other comprehensive loss by component for the first six months of 2018 were as follows (in thousands):
Foreign Currency Translation Adjustment
Unrealized Gains/(Losses) on Available-For-Sale Investments
Balance, December 31, 2017
Other comprehensive income (loss)

Balance, June 30, 2018